Alliance Pharma Share Price | |
---|---|
Price | 40.00 |
Bid | 39.95 |
Ask | 40.15 |
Change | 1.40 (3.63%) |
Volume | 3,478,382 |
Open | 37.00 |
High | 40.10 |
Low | 37.00 |
Prev. Close | 38.60 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £216.16m |
Market Size | 20,000 |
52 Week High | 62.90 |
52 Week High Date | 30-May-2023 |
52 Week Low | 24.55 |
52 Week Low Date | 08-May-2024 |
# Trades | 356 |
---|---|
Vol. Sold | 1,658,107 |
Sold Value | £652.77k |
Vol. Bought | 1,471,730 |
Bought Value | £579.86k |
PE Ratio | 235.29412 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.228% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-May-24 | 17:11:18 | 40.00 | 100,000 | Unknown* | 39.95 | 40.15 | 40.00k | O Ordinary Was reported as OTC |
24-May-24 | 16:35:39 | 40.00 | 24,823 | Sell* | 39.95 | 40.15 | 9,929 | O Ordinary |
24-May-24 | 16:35:12 | 40.00 | 203,399 | Sell* | 39.95 | 40.15 | 81.36k | UT Uncrossing Trade |
24-May-24 | 16:29:47 | 39.95 | 2,471 | Sell* | 39.95 | 40.15 | 987.16 | A Automatic Execution |
24-May-24 | 16:29:42 | 39.95 | 209 | Sell* | 39.95 | 40.15 | 83.50 | A Automatic Execution |
24-May-24 | 16:29:42 | 39.95 | 2,317 | Sell* | 39.95 | 40.15 | 925.64 | A Automatic Execution |
24-May-24 | 16:29:01 | 39.95 | 1,083 | Sell* | 39.95 | 40.15 | 432.66 | A Automatic Execution |
24-May-24 | 16:29:01 | 39.95 | 2,906 | Sell* | 39.95 | 40.15 | 1,161 | A Automatic Execution |
24-May-24 | 16:28:36 | 40.0786 | 2,495 | Buy* | 39.95 | 40.15 | 999.96 | O Ordinary |
24-May-24 | 16:24:47 | 40.098 | 205 | Buy* | 39.95 | 40.15 | 82.20 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions